DUBLIN–(BUSINESS WIRE)–The “Global Pharmaceutical Contract Manufacturing Service – Procurement Market Intelligence Report” report has been added to ResearchAndMarkets.com’s offering.
The category spend momentum is attributed to the cost savings of about 28%-32% that contract manufacturing of drugs enables while enhancing the drug development process. CMOs provide access to novel technologies and innovative platforms that can enhance speed-to-market and help buyers to remain competitive.
This report provides actionable insights to improve source-to-contract cycle performance in the Global Pharmaceutical Contract Manufacturing Services Market. It helps sourcing professionals formulate better category strategies, enhance savings, understand supplier and market challenges, and implement sourcing best practices.
The report provides up-to-date information about market shifts and potential risks, as well as in-depth knowledge of products and services, which can help in planning and in executing category management activities. It focuses on the cost-saving aspects of procurement and on providing insights that can lead to optimization of category spend.
One of the procurement best practices for buyers in the global pharmaceutical contract manufacturing service market is to establish a supplier quality enhancement program.
According to the report, one of the key growth drivers for the global pharmaceutical contract manufacturing service market is the high demand for pharmaceutical contract manufacturing services from biopharmaceutical industry. The biopharmaceutical industry is increasingly outsourcing services to CMOs due to the need for additional capacity and access to capabilities and technologies that they lack.
Further, the report states that one of the key procurement challenges faced by buyers is the difficulty in demand forecasting for biologic drug production. The biologics drug development and approval process are long and fraught with complications, resulting in risk of inaccurately forecasting demand.
Category drivers
- Advances in medical science such as stem cell research and combination drug therapy
- For a full, detailed list, view the report…
Category management strategy
- Rationalization of the supply base
- For a full, detailed list, view the report…
Procurement best practices
- Establish quality enhancement programs for suppliers
- For a full, detailed list, view the report…
Key questions answered in this report
- What are the market dynamics?
- What are the key market trends?
- What are the category growth drivers?
- What are the constraints on category growth?
- Who are the suppliers in this market?
- What are the demand-supply shifts?
- What are the major category requirements?
- What are the procurement best practices in this market?
Key Topics Covered
PART 01: Executive Summary
Global category spend
Category spend growth
Spend segmentation by region
Regional spend dynamics
Regional influence on global spend
Regional spend opportunity for suppliers
PART 02: Market Summary
PART 03: Category Pricing Insights
Pricing outlook
Supplier cost structure
Outlook for input costs
Total cost of ownership analysis
Overview of pricing models
Comparison of pricing models
Supply chain margins
Cost drivers impacting pricing
Volume drivers impacting pricing
PART 04: Cost-Saving Opportunities
Supplier-side levers
Buyer-side levers
Quantifying cost-saving opportunities
Quantifying cost savings by negotiation strategies
PART 05: Best Practices
Innovation and success stories
Procurement excellence best practices
Procurement best practices
Sustainability practices
PART 06: Category Ecosystem
Market favorability index for suppliers
Competitiveness index for suppliers
Buyer power
Supplier power score
Threat of new entrants
Threat of substitutes
Buyer ecosystem
Supplier ecosystem
PART 07: Category Management Strategy
Category management objectives
Supplier and buyer KPIs
Outsourcing category management activities
Risk management
PART 08: Category Management Enablers
Procurement organization
Category enablers
PART 09: Suppliers Selection
RFx essentials
Supplier selection criteria
Service level agreement
Incumbent supplier evaluation metrics
PART 10: Suppliers Under Coverage
Overview
Supplier positioning
Profile: Pfizer
Profile: Boehringer Ingelheim
Profile: Lonza
Profile: Baxter
Profile: Catalent
Profile: Fresenius Kabi
PART 11: US Market Insights
Category spend in the US
Price outlook
Supplier cost structure in the US
Margins of suppliers in the US
Category cost drivers
Category volume drivers
Overview of best practices in the US
Procurement best practices in the US
US supply market overview
Supplier positioning for the US
Regional category risks
PART 12: Category Definition
Category hierarchy
Category scope
Category map
For more information about this report visit https://www.researchandmarkets.com/r/8creaj
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900